Effect of low weekly doses of mifepristone on ovarian function and endometrial development

Human Reproduction

Volumn 11, Issue 2, 1996, Pages 256-264

  Gemzell Danielsson, K ^a   Westlund, P ^a   Johannisson, E ^b   Swahn, M L ^a   Bygdeman, M ^a   Seppala M ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Hôpital Cantonal   (Switzerland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Antiprogestin; Endometrial development; Implantation; Ovulation; Progesterone receptors

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; ESTRONE GLUCURONIDE; HYDROCORTISONE; LUTEINIZING HORMONE; MIFEPRISTONE; PLACENTA PROTEIN 14; PREGNANEDIOL; PROGESTERONE; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG SAFETY; ENDOMETRIUM; ENDOMETRIUM BIOPSY; ENZYME IMMUNOASSAY; ESTROGEN URINE LEVEL; FEMALE; FOLLICULAR PHASE; HORMONE URINE LEVEL; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; LECTIN BINDING; LUTEAL PHASE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; OVARY FUNCTION; OVULATION; PROGESTERONE URINE LEVEL; RECEPTOR DENSITY; TRANSVAGINAL ECHOGRAPHY;

DOLICHUS; DOLICHUS BIFLORUS;

EID: 0029870685     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/HUMREP/11.2.256     Document Type: Article

References (38)

1. Batista, M.C., Cartledge, T.P., Zellmer, A.W., Nieman, L.K., Merriam, G.R. and Loriaux, D.L. (1992a) Evidence for a critical role of progesterone in the regulation of the midcycle gonadotropin surge and ovulation. J. Clin. Endocrinol. Merab , 74, 565-570.
2. Batista, M.C., Cartledge, T.P., Zellmer, A.W., Merino, M J., Axiotis, C., et al., (1992b) Delayed endometrial maturation induced by daily administration of the antiprogestin RU486. A potential new. contraceptive strategy. Am. J. Obstet. Gynecol., 167, 60-65.
3. Batista, M.C., Cartledge, T.P., Zellmer, A.W., Nieman, L.K., Lonaux, D.L. and Merriam, G.R. (1994) The antiprogestin RU486 delays the midcycle gonadotrophin surge and ovulation in gonadotrophin-releasing hormone-induced cycles. Fertil. Steril., 62, 28-34.
4. Berthois, Y., Salat-Baroux, J., Cornet, D., De Brux, J., Kopp, F. and Marie Martin, P (1991) A multicenter parametric analysis of endometrial estrogen and progesterone receptors after the postovulatory administration of mifepristone. Fertil. Steril., 55, 547-554.
5. Cekan, S.Z., Beksac, M.S., Wang, E., Shi, S., Masironi, B., et al., (1986) The prediction and/or detection of ovulation by means of urinary steroid assays. Contraception. 33, 327-345.
6. Croxatto, H.B. and Salvatierra, A.M. (1991) Cyclic use of antigestagen for fertility control. In Runnebaum. B., Rabe, T. and Kisel, L. (eds). Female Contraception and Male Fertility Regulation. Parthenon, London, pp. 145-152.
7. Croxatto, H.B., Spitz, I.M., Salvatierra, A.M. and Bardin, C.W. (1985) The demonstration of the antiprogestin effects of RU486 when administered to the human during hCG-induced pseudopregnancy. In Baulieu, E.E. and Segal,S.J. (eds), The Antiprogestin Steroid RU486 and Human Fertility Control. Plenum Press, New York, pp 263-269.
8. Croxatto, H.B., Salvatierra, A.M., Croxatto, H.B. and Fuentealba, B. (1993) Effects of continuous treatment with low dose mifepristone throughout one menstrual cycle. Hum. Reprod., 8, 201-207.
9. Gaddum, J. (1945) Lognormal distributions. Nature, 156, 463-466.
10. Gemzell, K. Swahn, M.L. and Bygdeman, M. (1990) Regulation of non-pregnant human uterine contractility. Effect of anti hormones Contraception, 42, 323-335.
11. 2α concentrations. Hum. Reprod., 9, 1626-1630.
12. Gemzell-Danielsson, K., Swahn, M.L., Svalander, P. and Bygdeman, M. (1993) Early luteal phase treatment with RU486 for fertility regulation. Hum. Reprod., 8, 870-873.
13. Gemzell-Danielsson, K., Svalander, P., Swahn, M.L., Johannisson, E. and Bygdeman, M. (1994) Effects of a single post-ovulatory dose of RU486 on endometrial maturation in the implantation phase. Hum. Reprod., 9, 2398-2404.
14. Glasier, A.F. Thong, K J., Dewar, M., Mackie, M. and Baird, D.T. (1992) Mifepnstone (RU486) compared with high-dose estrogen and progesterone emergency postcoital contraception. N. Engl. J. Med., 327, 1041-1044.
15. Ishwad, P.C., Katkam, R.R., Hinduja, I.N., Chwalisz, K., Elger, W. and Puri, C.P. (1993) Treatment with a progesterone antagonist ZK 98.299 delays endometrial development without blocking ovulation in bonnet monkeys. Contraception, 48, 57-70.
16. Johannisson, E., Landgren, B.M., Rohr, H.P. and Diczfalusy, E. (1987) Endometrial morphology and peripheral hormone levels in women with regular menstrual cycles. Fertil. Steril., 38, 564-571.
17. Julkunen, M., Apter, D., Seppäla, M., Stenman, U -H. and Bohn, H. (1986) Serum levels of placental protein 14 reflect ovulation in nonconceptional menstrual cycles. Fertil. Steril., 45, 47-50.
18. Julkunen, M., Koistinen, R., Suikkari, A.-M., Seppälä, M. and Jänne, O.A. (1990) Identification by hybridization histochemistry of human endometrial cells expressing mRNAs encoding a uterine β-lactoglobulin homologue and insulin-like growth factor-binding protein-1. Mol. Endocrinol., 4, 700-707.
19. Ledger, W.L., Sweeting, V.M., Hillier, H. and Baird, D T. (1992) Inhibition of ovulation by low dose of mifepristone (MU 486). Hum. Reprod., 7, 945-950.
20. Liu, J.H., Garzo, G., Monis, S., Strenkel, C., Ulmann, A. and Yen, S.S.C. (1987) Disruption of follicular maturation and delay of ovulation after administration of the anti progesterone RU486. J. Clin. Endocrinol. Metab., 65, 1135-1140.
21. Luukkainen, T., Heikinheimo, O., Haukkamaa, M and Lahteenmaki, P. (1988) Inhibition of folliculogenesis and ovulation by the antiprogesterone RU486. Fertil Steril., 49, 961-963.
22. Maentausta, O., Svalander, P., Gemzell-Danielsson, K., Bygdeman, M. and Vikho, R. (1993) The effects of an antiprogesterone, mifepristone, and an antiestrogen. tamoxifen, on endometrial 17β-hydroxy steroid dehydrogenase and progestin and estrogen receptors during the luteal phase of the menstrual cycle: an immunohistochemical study. J. Clin. Endocrinol. Metab., 77, 913-918.
23. Mazur, M.T., Duncan, D A. and Younger, B. (1989) Endometrial biopsy in the cycle of conception. histologic and lectin histochemical evaluation. Fertil. Steril., 51, 764-769.
24. Metcalf, M. and Hunt, E G. (1976) Calculation of estrogen excretion rates from urinary estrogen to creatinine ratios. Clin. Biochem., 9, 75-77.
25. Parinaud, J., Perret, B., Ribbes, H., Vieitez, G. and Baulieu, E.E. (1990) Effects of RU486 on progesterone secretion by human preovulatory granulosa cells in culture. J. Clin. Endocrinol Metab., 70, 1534-1537
26. Philibert, D., Deraedt, R., Tournemine, C., Mary, I and Teutsch. G. (1982) RU 38486 - A potent antiprogesterone. J. Steroid Biochem., 17, Abstr. no. 204.
27. Press, M.F. Udove, J A and Greene, G.L. (1988) Progesterone receptor distribution in the human endometrium. Am. J. Pathol., 131, 112-124.
28. Puri, C.P. and Van Look, P.F.A. (1991) Newly developed competitive progesterone antagonists for fertility control. Front. Horm. Res., 19, 127-167.
29. Rizk, B., Manners, C.V., Davies, M.C., Steer, C.V., Bell, S.C., et al., (1992) Immunohistochemical expression of endometrial proteins and pregnancy outcome in frozen embryo replacement cycles. Hum. Reprod., 7, 413-417.
30. Schoupe, D., Mishell, D.R., Page, M.A., Madkour, H., Spitz, J.M. and Lobo, R.A. (1987) Effects of the antiprogesterone RU486 in the late follicular phase. Am. J. Obstet. Gynecol., 157, 1421-1426.
31. Seppälä, M., Rönnberg, L., Karonen, S.L. and Kauppila, A. (1987) Micronized progesterone increases the circulating level of endometrial secretory PP14/ beta-lactoglobulin homologue. Hum. Reprod., 2, 453-435.
32. Spitz, J.M., Croxatto, H.B., Salvatierra, A.M. and Heikinheimo, O. (1993) Response to intermittent RU486 in women. Fertil. Steril., 59, 971-975.
33. Sufi, B., Donaldson, A. and Jeffcoate, S.L. (1986) Method Manual, 10th edn. WHO Programme for the Provision of Matched Assay Reagents, Geneva, Switzerland.
34. Swahn, M.L., Johannisson, E., Daniore, V., de la Torre, B. and Bygdeman, M. (1988) The effect of RU486 administered during the proliferative and secretory phase of the cycle on die bleeding pattern, hormonal parameters and the endometrium. Hum. Reprod., 8, 915-921.
35. Swahn, M.L., Bygdeman, M., Xing, S., Cekan, S., Masironi, B and Johannisson. E. (1990) The effects of RU486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium. Hum. Reprod., 5, 402-408.
36. Swahn, M.L., Bygdeman, M., Seppälä, M., Johannisson, E. and Cekan, S (1993) Effect of tamoxifen alone and in combination with RU486 on the endometrium in the mid-luteal phase. Hum. Reprod., 8, 193-200.
37. Van Look, P.F.A. and Bygdeman, M. (1989) Antiprogestational steroids: a new dimension in fertility regulation. Oxford Rev. Reprod. Biol., 11, 1-60.
38. Yen, S C.C. (1993) Use of antiprogestin in the management of endometriosis and leiomyoma. In Donaldson. M S.S., Dorflinger, L., Brown, S.B. and Benel, L.Z. (eds). Clinical Applications of Mifepristone and Other Antiprogestins. National Academy Press, Washington, pp 189-199.